U.S. Women's Health Diagnostics Market, By Diagnostic Devices (Imaging and Monitoring Systems, Biopsy Devices, Reagents and Kits, Biomarkers and Others), Application (Osteoporosis Testing, OVC Testing, Cervical Cancer Testing, Breast Cancer Testing, Pregnancy and Fertility Testing, Prenatal Genetic Screening and Carrier Testing, Infectious Disease Testing, STD Testing and Ultrasound Tests), End User (Hospitals, Diagnostic and Imaging Centres, Clinics and Home Care Setting), Industry Trends and Forecast to 2028.
Market Analysis and Insights of Women's Health Diagnostics Market
Data Bridge Market Research analyses that the women's health diagnostics market will exhibit a CAGR of around 7.40% for the forecast period of 2021-2028. Rising prevalence of osteoporosis and other chronic disorders in women, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced healthcare technologies, and rising expenditure for the development of healthcare infrastructure especially in the developing economies are the major factors attributable to the growth of women's health diagnostics market.
From the name itself, it is clear that women's health diagnostics is a medical procedure involving diagnosis and treatment of conditions and diseases in women. A wide range of diseases and disorders can develop in women such as sexually transmitted infections (STIs), gynecology disorders, breast cancer, ovarian cancer, and others and this is where the role of women's health diagnostics arises.
Upsurge in the rate of pregnancy is one of the major factors fostering the growth of the market. Rise in the healthcare expenses in advanced countries and growing population of women in the workforce are other market growth determinants. Rising westernization, increasing number of imaging and diagnostic centres, surging prevalence of lifestyle disorders in women and rising medical tourism are other important factors that will further generate lucrative market growth opportunities.
However, improper and unfavourable reimbursement scenario in the developing and underdeveloped economies will derail the market growth rate. Also, high costs associated with research and development proficiencies and high costs associated with diagnostic imaging systems and procedures will further pose challenges for the market. Dearth of skilled professionals in the backward economies and stringent regulatory framework will also hamper the market growth rate.
This women's health diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on women's health diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
U.S. Women's Health Diagnostics Market Scope and Market Size
The women's health diagnostics market is segmented on the basis of diagnostic devices, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of diagnostic devices, the women's health diagnostics market is segmented into imaging and monitoring systems, biopsy devices, reagents and kits, biomarkers and others.
- On the basis of application, the women's health diagnostics market is segmented into osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing and ultrasound tests. Osteoporosis testing is further segmented into bone densitometry and in vitro blood tests. OVC testing is further segmented into OVC tumor marker tests, OVC diagnostic imaging tests and other OVC tests. Cervical cancer testing is further segmented into pap smears and HPV testing. Breast cancer testing is further segmented into mammography, breast cancer tumor marker tests, biopsies and other breast cancer tests. Pregnancy & fertility testing is further segmented into lab-based testing, pregnancy testing & ovulation prediction kits and fertility monitors. Prenatal genetic screening & carrier testing is further segmented into CF testing, down ’s syndrome and Edwards’ syndrome testing, torch testing and other prenatal genetic disease tests. Infectious disease testing is further segmented into MRSA testing, UTI testing, hepatitis testing, tuberculosis testing and other infectious disease tests. STD testing is further segmented into CT/NG testing, HIV testing and other STD Tests. Ultrasound tests are further segmented into breast imaging and OB/GYN imaging.
- On the basis of end user, the women's health diagnostics market is segmented into hospitals, diagnostic and imaging centers, clinics and home care setting.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The women's health diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the women's health diagnostics market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Women's Health Diagnostics Market Share Analysis
The women's health diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to women's health diagnostics market.
The major players covered in the women's health diagnostics market report are bioMérieux SA, Carestream Health, MEDGYN PRODUCTS, INC., COOK, Cardinal Health, PerkinElmer Inc. GENERAL ELECTRIC, Quest Diagnostics Incorporated, Sysmex Corporation, Siemens, Hologic Inc., Abbott, BD, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Koninklijke Philips N.V., NeuroLogica Corp., Danaher, FUJIFILM Holdings Corporation, Hitachi, Ltd., Canon Inc. among other. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.